|
RCAN3 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.707250E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.161840E-01 |
| Normal-vs-AfricanAmerican |
3.320800E-01 |
| Normal-vs-Asian |
2.786400E-01 |
| Caucasian-vs-AfricanAmerican |
3.382000E-01 |
| Caucasian-vs-Asian |
8.852800E-01 |
| AfricanAmerican-vs-Asian |
5.669400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.387600E-02 |
| Normal-vs-Female |
2.285800E-01 |
| Male-vs-Female |
4.243000E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.772200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.872400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.902030E-01 |
| Normal-vs-Age(81-100Yrs) |
1.155760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.020800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.722400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.570800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.539200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.868200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.743800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
1.563990E-01 |
| Normal-vs-Pheochromocytoma |
1.867200E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
8.479700E-02 |
| Paraganglioma-vs-Pheochromocytoma |
2.478600E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.626400E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.293600E-01 |
|
|
